ClinicalTrials.gov now lists over 530,000 registered studies across 226 countries, and a meaningful percentage of them compensate participants — but the site has no filter for “paid,” which means most people never find the ones offering real money. The fastest route is to go to clinicaltrials.gov, search your condition or area of interest, set the recruitment status to “Recruiting,” enter your zip code, then manually review individual listings for compensation language like “stipend,” “reimbursement,” or “honorarium.” Phase I trials for healthy volunteers routinely pay between $2,000 and $5,000, and longer inpatient stays can exceed $7,000. Even less intensive Phase II and III studies often pay several hundred to several thousand dollars over the course of participation.
This article walks through exactly how to navigate ClinicalTrials.gov’s search tools to surface paid opportunities, what realistic compensation looks like across different trial phases, which third-party platforms can match you to studies faster, and what safety protections exist so you can evaluate whether a given trial is worth your time. If you have never searched for a clinical trial before, the volume of listings can feel overwhelming. The goal here is to cut through that noise and give you a practical, step-by-step method for finding studies that actually pay — near where you live.
Table of Contents
- How Do You Find Paid Clinical Trials on ClinicalTrials.gov?
- What Do Clinical Trials Actually Pay in 2026?
- Third-Party Platforms That Match You to Paid Studies
- How to Evaluate Whether a Specific Trial Is Worth Your Time
- Safety Protections You Should Know Before Enrolling
- What to Do If There Are No Paid Trials in Your Area
- Where Clinical Trial Recruitment Is Heading
- Conclusion
- Frequently Asked Questions
How Do You Find Paid Clinical Trials on ClinicalTrials.gov?
ClinicalTrials.gov launched in 2000 after Congress passed legislation requiring public registration of clinical trials, largely because patient advocacy groups demanded transparency. Twenty-five years later, the database averages 35,000 new study registrations per year and draws roughly 2 million unique monthly visitors. About 148,000 of the listed studies are U.S.-based, with another 267,000 taking place in non-U.S. locations. The sheer size of the registry is both its greatest strength and its biggest practical problem: there is no dedicated checkbox or filter that lets you isolate paid studies from unpaid ones. To work around this, start on the ClinicalTrials.gov homepage and use the condition/disease field broadly — entering something like “healthy volunteer” or a specific condition you have.
Set the recruitment status to “Recruiting” so you only see active studies. Under the location filter, enter your city or zip code and set a radius you are willing to travel. Once results appear, you will need to click into individual study pages and look under the “Contacts and Locations” or “More Information” sections for compensation details. Some listings spell it out clearly (“participants will receive $150 per visit”), while others bury it in the full protocol or simply say “compensation provided.” It is manual work, but it is the most comprehensive starting point available. One comparison worth noting: if you search for phase I trials specifically — the early-stage safety studies that most often recruit healthy volunteers — you will find a much higher rate of paid listings than if you search broadly. Phase I trials are where pharmaceutical companies need large numbers of healthy participants quickly, and compensation is the primary incentive. Phase II and III trials, which involve patients with specific conditions, may offer lower per-visit payments but can still add up over months of participation.
What Do Clinical Trials Actually Pay in 2026?
Compensation varies dramatically by trial phase, duration, and what is asked of you physically. Published research indexed in PubMed found that the median compensation across Phase I trials is $3,070, with a range stretching from $150 on the low end to $13,000 for the most intensive studies. Phase I trials that require inpatient stays — where you live at a research facility for days or weeks — tend to pay the most, especially when biospecimen collection or round-the-clock monitoring is involved. Phase II trials, which test whether a drug works for a specific condition, typically pay between $300 and $3,000. Phase III trials, the large-scale studies that generate the data submitted to the FDA for drug approval, range from $2,000 to $7,000 due to their longer duration. However, if you are imagining clinical trials as a full-time income source, the math gets sobering quickly.
Typical participants screen for about three studies per year, enroll in one or two, and earn roughly $4,000 annually. Screening itself can take weeks, and not everyone who screens actually qualifies. Washout periods between trials — mandatory gaps required by most research sites — further limit how many studies you can do consecutively. Compensation is also structured in different ways: some studies pay per visit, others offer milestone payments at key checkpoints, and many reserve a completion bonus that you forfeit if you drop out early. Travel reimbursement may be separate from the actual stipend, so read the terms carefully. One detail that catches people off guard: clinical trial payments are taxable income. The IRS requires that you report what you earn, and research sites that pay you over $600 in a year will typically issue a 1099 form. By 2026, compensation trends have been moving toward more digital, more frequent, and more standardized payment methods — prepaid debit cards and digital wallets are increasingly common — but the tax obligation remains the same regardless of how you receive the money.
Third-Party Platforms That Match You to Paid Studies
ClinicalTrials.gov is comprehensive but not user-friendly for people whose primary goal is finding paid opportunities. Several third-party platforms exist specifically to bridge that gap, and each has a different approach worth understanding. ResearchMatch, found at researchmatch.org, is a free nonprofit platform supported by the National Institutes of Health. You create a profile with your health information and demographics, and researchers at leading medical institutions across the country can reach out to you when you match a study’s criteria. The advantage is that ResearchMatch is vetted and legitimate. The limitation is that it leans heavily toward academic research, which may or may not offer competitive compensation. Antidote, at antidote.me, takes a different approach. It is a digital matching platform that has partnered with over 180 patient advocacy organizations — groups like JDRF, the National Kidney Foundation, and the Lung Cancer Alliance.
If you have a specific health condition, Antidote can be particularly effective because it connects directly with disease-focused communities and the trials recruiting from them. For healthy volunteers without a specific condition, Antidote is less useful. Fortrea, a contract research organization at fortreaclinicaltrials.com, runs its own clinical trial sites and actively recruits paid participants at locations in Dallas, Texas; Madison, Wisconsin; and Daytona Beach, Florida. You can call them directly at 1-866-429-7700 to ask about currently enrolling studies. Fortrea tends to run the kind of Phase I inpatient trials that pay on the higher end of the spectrum. In early 2026, Mount Sinai launched an AI-powered clinical trial matching platform designed specifically to expand access to cancer research trials. This is a signal of where the field is heading — large medical institutions building their own matching tools to reduce the friction of enrollment. For now, though, the most reliable strategy is to use ClinicalTrials.gov as your master search engine and supplement it with one or two of these matching platforms based on your profile.
How to Evaluate Whether a Specific Trial Is Worth Your Time
Not all paid trials are created equal, and the dollar amount alone is a poor way to evaluate an opportunity. The real calculation involves compensation per hour of your time, the physical demands, the travel burden, and the restrictions placed on your life during participation. A trial paying $5,000 over six weeks of inpatient confinement works out differently than one paying $1,500 for four outpatient visits spread over two months. The inpatient study pays more in total but requires you to live at a facility, follow a controlled diet, and submit to frequent blood draws. The outpatient study pays less but lets you maintain your normal routine. Read the informed consent document thoroughly before agreeing to anything. Federal regulations require that every participant receive this document, and it must detail the study’s purpose, procedures, risks, benefits, alternatives, and your rights.
Pay particular attention to the schedule of events — this tells you exactly how many visits are required, what happens at each one, and how long each visit takes. Compare that against the compensation structure. If a study requires 12 clinic visits over six months but only pays a completion bonus at the end, you are carrying all the time and travel costs upfront with no guarantee of payment if life circumstances force you to withdraw early. Studies that pay per visit shift less risk onto you. Also consider the washout and exclusion implications. Participating in one trial may disqualify you from others for 30 to 90 days afterward, and some studies require you to stop taking certain medications. If you are weighing two opportunities, the one with a shorter washout period and fewer medication restrictions may be the better choice even if it pays slightly less, because it gets you back into eligibility for the next study sooner.
Safety Protections You Should Know Before Enrolling
Every federally funded or FDA-regulated clinical trial in the United States must be approved by an Institutional Review Board before a single participant enrolls. The IRB is an independent committee — typically composed of scientists, doctors, ethicists, and community members — whose job is to evaluate whether the study’s potential benefits justify its risks and whether participants are adequately protected. This is not a rubber stamp process. IRBs can and do reject studies, require protocol modifications, or shut down ongoing trials if safety concerns emerge. FDA regulations also require ongoing continuing review throughout the life of the trial, meaning the IRB revisits its approval periodically rather than just signing off once at the beginning. Informed consent is the other major safeguard, and it is worth understanding what it actually means in practice. The research team must explain the study to you in language you can understand — not just hand you a stack of legal paperwork.
You have the right to ask questions, take the document home, discuss it with your doctor or family, and take as long as you need before deciding. Critically, you can withdraw from any clinical trial at any time, for any reason, without penalty. No study can require you to stay, and withdrawing does not affect your access to standard medical care. One area where misconceptions persist is placebos. Federal regulations restrict the use of placebos to situations where receiving a placebo would not cause increased risk or harm to the participant. In practice, this means that if an effective treatment already exists for your condition, a trial generally cannot assign you to a sugar pill and leave you untreated. Many modern trials use “active comparator” designs where every participant receives some form of treatment, though not necessarily the experimental one. If a study’s consent form mentions a placebo arm, ask the research coordinator directly what standard of care you would receive if assigned to that group.
What to Do If There Are No Paid Trials in Your Area
Geography is a real barrier. If you live in a rural area or a region without major research hospitals, ClinicalTrials.gov’s location filter may return few or no results within a reasonable driving distance. Before giving up, try expanding your search radius to 100 or even 200 miles — some high-paying inpatient trials cover travel costs or provide housing, which changes the math on distance. Also search without a location filter and sort by state to see if there are clusters of trials in the nearest metro area that you could travel to for screening visits.
Remote and decentralized clinical trials have grown substantially since the pandemic accelerated their adoption. Some studies now conduct visits via telemedicine, ship medications to your home, and use wearable devices or smartphone apps to collect data — meaning you may never need to visit a clinic in person. These are still a minority of all trials, but the number is growing. On ClinicalTrials.gov, look for keywords like “decentralized,” “virtual,” or “remote” in the study description. ResearchMatch and Antidote also flag remote-eligible studies in their matching results.
Where Clinical Trial Recruitment Is Heading
The clinical trial landscape is shifting in ways that favor participants. Mount Sinai’s 2026 launch of an AI-powered matching platform is one example of a broader trend: institutions are investing in technology that reduces the historically painful process of finding and enrolling in studies. For decades, clinical trials have struggled with recruitment — an estimated 80 percent of trials fail to meet enrollment timelines — and that problem has created real financial incentives for sponsors to make participation easier and better compensated.
Compensation standards are also becoming more formalized. The push toward digital, frequent, and standardized payment methods reflects growing recognition that delayed or cumbersome payments discourage enrollment, particularly among participants from lower-income backgrounds who need the money promptly. As competition for participants increases and regulatory scrutiny around equitable access grows, expect payment transparency and speed to continue improving. The days of receiving a check in the mail six weeks after your last visit are giving way to real-time stipend deposits after each completed visit.
Conclusion
ClinicalTrials.gov remains the most comprehensive starting point for finding paid research studies, with over 530,000 registered trials across 226 countries and roughly 148,000 based in the United States. The absence of a dedicated compensation filter means you will need to do some manual work — searching by location and recruitment status, then reviewing individual listings — but supplementing that search with platforms like ResearchMatch, Antidote, and Fortrea can surface opportunities faster. Realistic compensation for most participants falls in the range of $1,000 to $5,000 per study, with the highest payments concentrated in Phase I inpatient trials for healthy volunteers.
Before enrolling in anything, read the informed consent document carefully, understand the time commitment and visit schedule, confirm the compensation structure and payment timing, and verify that the study has IRB approval. You can withdraw at any time without penalty. Clinical trials are one of the few ways to earn meaningful compensation while contributing to medical research, but they require the same due diligence you would apply to any other commitment of your time and health.
Frequently Asked Questions
Does ClinicalTrials.gov have a filter for paid studies?
No. There is no dedicated compensation filter on ClinicalTrials.gov. You must search by condition, location, and recruitment status, then manually check individual study listings for language about stipends, reimbursement, or honoraria.
How much do Phase I clinical trials pay?
Published research in PubMed found median Phase I compensation of $3,070, with a range from $150 to $13,000. Long inpatient stays with intensive monitoring or biospecimen collection tend to pay the most, sometimes exceeding $7,000.
Do I have to pay taxes on clinical trial compensation?
Yes. Clinical trial payments are taxable income. The IRS requires you to report this income, and research sites paying you more than $600 in a calendar year will typically issue a 1099 form.
Can I drop out of a clinical trial after I enroll?
Yes. Participants can withdraw from any clinical trial at any time, for any reason, without penalty. However, check the compensation terms — some studies withhold a completion bonus if you leave early.
How many clinical trials can I do per year?
Most participants screen for about three studies per year and enroll in one or two, earning roughly $4,000 annually. Washout periods between studies and eligibility requirements limit how quickly you can move from one trial to the next.
Are there clinical trials I can do from home?
Yes. Decentralized and virtual trials have grown significantly, with some studies conducting visits via telemedicine, shipping medications to participants, and collecting data through wearable devices or apps. Search for terms like “decentralized,” “virtual,” or “remote” on ClinicalTrials.gov.
